Form D · Pharmaceuticals
Araxes Pharma, LLC
La Jolla, CA · CIK 0001590712
Offering snapshot reported Nov 7, 2013 · SEC filing
- Reported sold
- $1.04M Offering amount: $1.04M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2013 | Initial | $1,042,263 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-205984
Includes amounts receivable upon exercise of a warrant to purchase units; such warrant has not yet been exercised.
Source: Form D, filed Nov 7, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Heidi Henson | Executive |
| Troy Wilson | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
11119 N. Torrey Pines Rd. Suite 125
La Jolla, CA, 92037
La Jolla, CA, 92037